Savara announces new employment inducement grant under nasdaq listing rule 5635(c)(4)

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees. on april 22, 2022, the compensation committee of savara's board of directors granted inducement awards to two new employees who recently joined the company. the inducement awards consist of options to purchase an aggregate of 55,000 shares of the company's common stock. these equity award
SVRA Ratings Summary
SVRA Quant Ranking